Lilly’s Newest Bull Says Near 300% Rally Is Only the Beginning
Eli Lilly & Co. has reached a market value exceeding $1 trillion following a nearly 300% stock rally over the last four years. The surge began after the approval of its first GLP-1 medication. It is now the world’s most valuable pharmaceutical company.
Eli Lilly & Co. has surged about 300% since its first GLP-1 was approved over four years ago, propelling it past $1 trillion in market value and making it the world’s most valuable pharmaceutical company.
READ NEXT
More on the wire
FROM THE PUBLISHER
Hi, friends! Welcome to Installer No. 144, your guide to the best and Verge-iest stuff in the world. (If you're new here, welcome, new tech season is here, and also you can read all the old editions at the Installer homepage.) This week, I flew out to Los Angeles to try on and write about […]
FROM THE PUBLISHER
The same calculator has been on most kids' back to school shopping list since the early 2000's and the dominance of Texas Instruments' calculator division goes back even farther. In the next episode of Version History, David Pierce is joined by The Verge's Nilay Patel and Victoria Song to tell the story of TI graphing […]
FROM THE PUBLISHER
Before recent high-profile hacks raised the specter of AI possibly "killing all humans," our energy systems were already disturbingly vulnerable to cyberattack - and the risk is growing. "We were always prey. We were just kind of surviving at the appetite of our predators," Joshua Corman, executive in residence for public safety and resilience at […]